Indian Drug Exporters Face Formidable New Rules In EU
This article was originally published in PharmAsia News
Indian drug makers may find it difficult to export their wares to the European Union after Nov. 30. EU law says all drugs and chemical products, foreign and domestic, must be registered by that date with the European Chemicals Agency. The registration rules are extensive and detailed and must be followed or products cannot be allowed in the EU. Pharmaceuticals are estimated to comprise more than 35 percent of the Indian chemicals exported to the EU, yet few companies appear aware of the costly new requirement. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.